Chondroitin Sulfate and Fucosylated Chondroitin Sulfate as Stimulators of Hematopoiesis in Cyclophosphamide-Induced Mice.

chondroitin sulfate cyclophosphamide fucosylated chondroitin sulfate graft versus host disease granulocyte colony-stimulating factor hematopoiesis immunosuppression

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
24 Oct 2021
Historique:
received: 19 08 2021
revised: 19 10 2021
accepted: 20 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 28 11 2021
Statut: epublish

Résumé

The immunosuppression and inhibition of hematopoiesis are considered to be reasons for the development of complications after intensive chemotherapy and allogeneic hematopoietic stem cell transplantation. Chondroitin sulfate (

Identifiants

pubmed: 34832856
pii: ph14111074
doi: 10.3390/ph14111074
pmc: PMC8623974
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministry of Science and Higher Education of the Russian Federation
ID : 075-15-2020-777

Références

Int J Biol Sci. 2012;8(9):1237-47
pubmed: 23136552
Clin Investig. 1994;72(6 Suppl):S36-43
pubmed: 7950171
Bone Marrow Transplant. 2009 Jun;43(12):895-908
pubmed: 19363527
Therap Adv Gastroenterol. 2020 May 20;13:1756284820924194
pubmed: 32547639
Pharmacogenomics. 2016 Mar;17(4):367-74
pubmed: 26894931
Mol Cancer Res. 2014 Oct;12(10):1416-29
pubmed: 24962319
Front Immunol. 2017 Jun 08;8:667
pubmed: 28642760
Bone Marrow Transplant. 2018 Sep;53(9):1139-1148
pubmed: 29540849
Science. 1996 Jan 26;271(5248):509-12
pubmed: 8560266
J Cancer Sci Ther. 2019;11(4):
pubmed: 32148661
Matrix Biol. 2019 Jan;75-76:314-330
pubmed: 29894820
J Transplant. 2014;2014:980301
pubmed: 25405023
Carbohydr Polym. 2017 Jul 1;167:20-26
pubmed: 28433155
Echocardiography. 2019 Mar;36(3):495-502
pubmed: 30636342
Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188387
pubmed: 32579889
Glycobiology. 2007 May;17(5):541-52
pubmed: 17296677
BMC Pharmacol Toxicol. 2014 Feb 21;15:7
pubmed: 24555723
J Clin Oncol. 2006 Nov 20;24(33):5207-15
pubmed: 17114653
Cancer Biol Med. 2020 Nov 15;17(4):896-909
pubmed: 33299642
Cytokine. 2021 Jun;142:155479
pubmed: 33677228
Int J Mol Sci. 2016 Nov 01;17(11):
pubmed: 27809289
Glycobiology. 2016 May;26(5):449-59
pubmed: 26681734
Oncology (Williston Park). 2015 Apr;29(4):282-94
pubmed: 25952492
Inflammopharmacology. 2011 Dec;19(6):299-306
pubmed: 22042237
Anticancer Res. 2019 Aug;39(8):4455-4462
pubmed: 31366544
Biol Blood Marrow Transplant. 2012 Aug;18(8):1150-63
pubmed: 22510384
Mar Drugs. 2014 Jan 09;12(1):232-54
pubmed: 24413804
Adv Immunol. 1993;54:271-335
pubmed: 8379464
Circulation. 2004 Jun 8;109(22):2749-54
pubmed: 15148277
Mar Drugs. 2017 Sep 30;15(10):
pubmed: 28973980
J Ophthalmol. 2020 Aug 11;2020:1537689
pubmed: 32850138
Expert Rev Hematol. 2017 May;10(5):479-492
pubmed: 28395546
Cancer Res. 2019 Sep 15;79(18):4567-4576
pubmed: 31431464
An Pediatr (Engl Ed). 2019 Oct;91(4):256-263
pubmed: 30777719
Mar Drugs. 2013 Jul 12;11(7):2444-58
pubmed: 23857111
Mar Drugs. 2018 Oct 17;16(10):
pubmed: 30336613
Pharmaceuticals (Basel). 2020 Jul 26;13(8):
pubmed: 32722596
Int Immunopharmacol. 2021 Mar;92:107349
pubmed: 33486323
Clin Exp Hepatol. 2018 Sep;4(3):182-190
pubmed: 30324143
Carbohydr Res. 2008 Oct 13;343(15):2605-12
pubmed: 18619579
Front Cell Dev Biol. 2017 Mar 07;5:18
pubmed: 28326306
Carbohydr Polym. 2017 Jun 1;165:7-12
pubmed: 28363577
Biol Blood Marrow Transplant. 2011 Dec;17(12):1862-8
pubmed: 21745454
Biol Res Nurs. 2015 Oct;17(5):549-57
pubmed: 25406461
Int J Biol Macromol. 2020 Jul 1;154:1123-1131
pubmed: 31751735
Semin Oncol. 2006 Feb;33(1):50-67
pubmed: 16473644
Mar Drugs. 2018 Sep 13;16(9):
pubmed: 30216993
Eur J Pharmacol. 2014 Oct 5;740:364-78
pubmed: 25058905
Crit Rev Oncol Hematol. 2020 Jan;145:102837
pubmed: 31830663
Carbohydr Polym. 2016 Nov 20;153:399-405
pubmed: 27561511

Auteurs

Nadezhda E Ustyuzhanina (NE)

N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, 119991 Moscow, Russia.

Natalia Yu Anisimova (NY)

N.N. Blokhin National Medical Research Center of Oncology, Kashirskoe Shosse 24, 115478 Moscow, Russia.

Maria I Bilan (MI)

N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, 119991 Moscow, Russia.

Fedor V Donenko (FV)

N.N. Blokhin National Medical Research Center of Oncology, Kashirskoe Shosse 24, 115478 Moscow, Russia.

Galina E Morozevich (GE)

V.N. Orekhovich Research Institute of Biomedical Chemistry, Pogodinskaya Str. 10, 119121 Moscow, Russia.

Dmitriy V Yashunskiy (DV)

V.N. Orekhovich Research Institute of Biomedical Chemistry, Pogodinskaya Str. 10, 119121 Moscow, Russia.

Anatolii I Usov (AI)

N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, 119991 Moscow, Russia.

Nara G Siminyan (NG)

N.N. Blokhin National Medical Research Center of Oncology, Kashirskoe Shosse 24, 115478 Moscow, Russia.

Kirill I Kirgisov (KI)

N.N. Blokhin National Medical Research Center of Oncology, Kashirskoe Shosse 24, 115478 Moscow, Russia.

Svetlana R Varfolomeeva (SR)

N.N. Blokhin National Medical Research Center of Oncology, Kashirskoe Shosse 24, 115478 Moscow, Russia.

Mikhail V Kiselevskiy (MV)

N.N. Blokhin National Medical Research Center of Oncology, Kashirskoe Shosse 24, 115478 Moscow, Russia.

Nikolay E Nifantiev (NE)

N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, 119991 Moscow, Russia.

Classifications MeSH